Clinical and pharmacological group: Oral hypoglycemic drug
Pharmacotherapeutic group: Hypoglycemic agent for oral use of the 3rd generation sulfonylurea group
Clinical and pharmacological group: Oral hypoglycemic drug
Pharmacotherapeutic group: Hypoglycemic agent for oral use of the 3rd generation sulfonylurea group
Bydureon is an injectable drug containing Exenatide that is used to improve glycemic control in adults with (non-insulin dependent) type 2 diabetes mellitus.
Bydureon is an injectable drug containing Exenatide that is used to improve glycemic control in adults with (non-insulin dependent) type 2 diabetes mellitus.
Bydureon is an injectable drug containing Exenatide that is used to improve glycemic control in adults with (non-insulin dependent) type 2 diabetes mellitus.